mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.075 |
0.1 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.41 |
0.1 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.1 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.1 |